109 related articles for article (PubMed ID: 35985506)
1. Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial.
Fernández-García JC; Barrios-Rodríguez R; Asenjo-Plaza M; Ramos-Molina B; Molina-Vega M; Guzmán-Guzmán A; Moreno-León L; Yubero-Serrano EM; Rius-Díaz F; Valdés S; Martínez-González MÁ; Jiménez-Moleón JJ; Tinahones FJ
Metabolism; 2022 Nov; 136():155290. PubMed ID: 35985506
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
3. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
4. Addition of metformin to sildenafil treatment for erectile dysfunction in eugonadal nondiabetic men with insulin resistance. A prospective, randomized, double-blind pilot study.
Rey-Valzacchi GJ; Costanzo PR; Finger LA; Layus AO; Gueglio GM; Litwak LE; Knoblovits P
J Androl; 2012; 33(4):608-14. PubMed ID: 22016348
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with metformin and fenofibrate for insulin resistance in obesity.
Li XM; Li Y; Zhang NN; Xie YH; Shi YQ
J Int Med Res; 2011; 39(5):1876-82. PubMed ID: 22117989
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
[TBL] [Abstract][Full Text] [Related]
7. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.
Deehan EC; Colin-Ramirez E; Triador L; Madsen KL; Prado CM; Field CJ; Ball GDC; Tan Q; Orsso C; Dinu I; Pakseresht M; Rubin D; Sharma AM; Tun H; Walter J; Newgard CB; Freemark M; Wine E; Haqq AM
Trials; 2021 Feb; 22(1):148. PubMed ID: 33596993
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
11. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
Avilés-Santa L; Sinding J; Raskin P
Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
[TBL] [Abstract][Full Text] [Related]
13. Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study.
Pelusi C; Giagulli VA; Baccini M; Fanelli F; Mezzullo M; Fazzini A; Bianchi N; Carbone MD; De Pergola G; Mastroroberto M; Morselli Labate AM; Pasquali R
PLoS One; 2017; 12(9):e0183369. PubMed ID: 28886024
[TBL] [Abstract][Full Text] [Related]
14. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
[TBL] [Abstract][Full Text] [Related]
15. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
Atabek ME; Pirgon O
J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.
Bridger T; MacDonald S; Baltzer F; Rodd C
Arch Pediatr Adolesc Med; 2006 Mar; 160(3):241-6. PubMed ID: 16520442
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
18. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
[TBL] [Abstract][Full Text] [Related]
19. Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting.
Knoblovits P; Costanzo PR; Valzacchi GJ; Gueglio G; Layus AO; Kozak AE; Balzaretti MI; Litwak LE
J Androl; 2010; 31(3):263-70. PubMed ID: 19834133
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes.
Tan MH; Glazer NB; Johns D; Widel M; Gilmore KJ
Curr Med Res Opin; 2004 May; 20(5):723-8. PubMed ID: 15140339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
